A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovirFIFE, Kenneth H; ALMEKINDER, Jennifer; OFNER, Susan et al.Sexually transmitted diseases. 2007, Vol 34, Num 5, pp 297-301, issn 0148-5717, 5 p.Article

Famciclovir reduces viral mucosal shedding in HSV-seropositive personsLEONE, Peter; WARREN, Terri; HAMED, Kamal et al.Sexually transmitted diseases. 2007, Vol 34, Num 11, pp 900-907, issn 0148-5717, 8 p.Article

Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes : The RELIEF trialBARTLETT, Brenda L; TYRING, Stephen K; FIFE, Kenneth et al.Journal of clinical virology. 2008, Vol 43, Num 2, pp 190-195, issn 1386-6532, 6 p.Article

Helicase―Primase Inhibitor Pritelivir for HSV-2 InfectionWALD, Anna; COREY, Lawrence; STOELBEN, Susanne et al.The New England journal of medicine. 2014, Vol 370, Num 3, pp 201-210, issn 0028-4793, 10 p.Article

External genital warts: Diagnosis, treatment, and preventionWILEY, D. J; DOUGLAS, John; BEUTNER, Karl et al.Clinical infectious diseases. 2002, Vol 35, pp S210-S224, issn 1058-4838, SUP2Article

HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couplesKAHLE, Erin; CAMPBELL, Mary; MULLINS, James I et al.AIDS (London). 2014, Vol 28, Num 2, pp 235-243, issn 0269-9370, 9 p.Article

Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive personsWALD, Anna; KOELLE, David M; FIFE, Kenneth et al.Vaccine. 2011, Vol 29, Num 47, pp 8520-8529, issn 0264-410X, 10 p.Article

An International, Randomized, Double-Blind, Placebo-Controlled, Study of Valacyclovir for the Suppression of Herpes Simplex Virus Type 2 Genital Herpes in Newly Diagnosed PatientsFIFE, Kenneth H; WARREN, Terri J; JUSTUS, Scott E et al.Sexually transmitted diseases. 2008, Vol 35, Num 7, pp 668-673, issn 0148-5717, 6 p.Article

Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasiaFIFE, Kenneth H; CRAMER, Harvey M; SCHROEDER, Jill M et al.Journal of medical virology. 2001, Vol 64, Num 4, pp 550-559, issn 0146-6615Article

Effect of Resiquimod 0.01% Gel on Lesion Healing and Viral Shedding When Applied to Genital Herpes LesionsFIFE, Kenneth H; MENG, Tze-Chiang; FERRIS, Daron G et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 2, pp 477-482, issn 0066-4804, 6 p.Article

The Effect of Daily Valacyclovir Suppression on Herpes Simplex Virus Type 2 Viral Shedding in HSV-2 Seropositive Subjects Without a History of Genital HerpesSPERLING, Rhoda S; FIFE, Kenneth H; WARREN, Terri J et al.Sexually transmitted diseases. 2008, Vol 35, Num 3, pp 286-290, issn 0148-5717, 5 p.Article

Human papillomavirus quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®). CommentarySIDDIQUI, M. Asif A; PERRY, Caroline M; FERRIS, Daron G et al.Drugs (Basel). 2006, Vol 66, Num 9, pp 1263-1273, issn 0012-6667, 11 p.Article

Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a dayFIFE, Kenneth H; FERENCZY, Alex; DOUGLAS, John M et al.Sexually transmitted diseases. 2001, Vol 28, Num 4, pp 226-231, issn 0148-5717Article

Outside Sexual Partnerships and Risk of HIV Acquisition for HIV Uninfected Partners in African HIV Serodiscordant PartnershipsNDASE, Patrick; CELUM, Connie; THOMAS, Katherine et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 1, pp 65-71, issn 1525-4135, 7 p.Article

Herpes Simplex Virus Type 2 Infection in Young Adult Women: Risk Factors for Infection and Frequency of Viral SheddinqFIFE, Kenneth H; WILLIAMS, James A; THOMAS, Allyson L et al.Sexually transmitted diseases. 2010, Vol 37, Num 4, pp 248-252, issn 0148-5717, 5 p.Article

Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral TherapyFIFE, Kenneth H; WU, Julia W; SQUIRES, Kathleen E et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 3, pp 274-282, issn 1525-4135, 9 p.Article

Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in menFIFE, Kenneth H; COPLAN, Paul M; JANSEN, Kathrin U et al.Sexually transmitted diseases. 2003, Vol 30, Num 3, pp 246-248, issn 0148-5717, 3 p.Article

Implementation of Routine Access to Herpes Simplex Virus Type 2 Antibody Testing in a Public Health Sexually Transmitted Disease ClinicFIFE, Kenneth H; VAN DER POL, Barbara; FORTENBERRY, J. Dennis et al.Sexually transmitted diseases. 2009, Vol 36, Num 11, pp 724-728, issn 0148-5717, 5 p.Article

Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes : A US-based randomized, double-blind, placebo-controlled clinical trialFIFE, Kenneth H; WARREN, Terri J; FERRERA, R. David et al.Mayo Clinic proceedings. 2006, Vol 81, Num 10, pp 1321-1327, issn 0025-6196, 7 p.Article

Plasma Viral Loads During Early HIV-1 Infection Are Similar in Subtype C― and Non-Subtype C― Infected African SeroconvertersCAMPBELL, Mary S; KAHLE, Erin M; CELUM, Connie et al.The Journal of infectious diseases. 2013, Vol 207, Num 7, pp 1166-1170, issn 0022-1899, 5 p.Article

Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpesFIFE, Kenneth H; BERNSTEIN, David I; WANZHU TU et al.Sexually transmitted diseases. 2004, Vol 31, Num 11, pp 676-681, issn 0148-5717, 6 p.Article

Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa : experience from western KenyaWOOLS-KALOUSTIAN, Kara; KIMAIYO, Silvester; DIERO, Lameck et al.AIDS (London). 2006, Vol 20, Num 1, pp 41-48, issn 0269-9370, 8 p.Article

Daily Oral Tenofovir and Emtricitabine—Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1―Uninfected Men and WomenCELUM, Connie; MORROW, Rhoda A; DONNELL, Deborah et al.Annals of internal medicine. 2014, Vol 161, Num 1, pp 11-19, issn 0003-4819, 9 p.Article

Factors predicting the acceptance of herpes simplex virus Type 2 antibody testing among adolescents and young adultsZIMET, Gregory D; ROSENTHAL, Susan L; FIFE, Kenneth H et al.Sexually transmitted diseases. 2004, Vol 31, Num 11, pp 665-669, issn 0148-5717, 5 p.Article

Return for results after herpes simplex virus type 2 screeningFORTENBERRY, J. Dennis; ZIMET, Gregory D; BRADY, Rebecca et al.Sexually transmitted diseases. 2004, Vol 31, Num 11, pp 655-658, issn 0148-5717, 4 p.Article